First isolation of an IMP-1 metallo-β-lactamase-producing Kluyvera ascorbata in Japan

Takeaki Wajima1, Yuji Hirai2, Takayuki Otake1

  • 1Department of Microbiology, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

Abstract

Insights

This study reports the first isolation of metallo-β-lactamase (MBL)-producing Kluyvera ascorbata from a pediatric patient. The findings highlight the potential for non-MBL-producing species to acquire MBL genes, posing a growing public health concern.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Rising global concern over carbapenemase-producing Enterobacterales.
  • Kluyvera ascorbata is not typically known as a metallo-β-lactamase (MBL)-producer.

Purpose of the Study:

  • To report the first isolation of an MBL-producing Kluyvera ascorbata strain.
  • To perform whole-genome analysis to understand the strain's features and the origin of IMP-1 MBL.
  • To investigate the transferability of the MBL-producing plasmid.

Main Methods:

  • Isolation of K. ascorbata from catheter-associated urine.
  • Confirmation of carbapenemase production using a modified carbapenemase inactivation method.
  • Whole-genome sequencing and conjugation ability evaluation.

Main Results:

  • TheblaIMP-1 gene was found on a transferable plasmid (pKATP2) with a class 1 integron structure.
  • The plasmid contained two repA genes and astA, and likely originated from the integration of multiple plasmids.
  • The plasmid harbored conjugation-associated genes and was transferable.

Conclusions:

  • This is the first report of MBL-producing K. ascorbata.
  • Species not typically producing MBLs can acquire these genes.
  • Such strains represent potential emerging pathogens requiring attention.

Related Concept Videos